By combining a Cas9 nickase with cytidine deaminase and uracil DNA glycosylase inhibitor (UGI) proteins to help the mutant CG pair to TA base pair conversion, the TP53 Tyr163Cys mutation in HCC1954 breast cancer cells has been rectified. This evidence concerns the gene TP53 and breast carcinoma.